CN Stock MarketDetailed Quotes
688163 Shanghai Serum Bio-Technology
- 20.36
- -0.15-0.73%
Market Closed Dec 11 15:00 CST
2.20BMarket Cap43.23P/E (TTM)
20.75High20.30Low13.28KlotVolume20.73Open20.51Pre Close27.17MTurnover2.99%Turnover Ratio56.87P/E (Static)108.22MShares22.9252wk High1.98P/B903.41MFloat Cap10.6652wk Low24.61Limit Up44.37MShs Float61.02Historical High16.41Limit Down2.19%Amplitude10.66Historical Low0.32Dividend TTM20.46Avg Price7.69KlotAsk1.57%Div YieldTTM100Lot Size5.31KlotBid
Shanghai Serum Bio-Technology Key Stats
EPS
According to the latest financial report of Shanghai Serum Bio-Technology, the latest earnings per share (TTM) for the company is 0.58. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: CNY
Cumulative Quarterly
Loading...
BVPS
Analyzing a company's fundamentals? Check out Shanghai Serum Bio-Technology's latest financial report to see how much their book value per share (BVPS) is currently at 10.30.
Currency: CNY
Cumulative Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Shanghai Serum Bio-Technology shows that the company's current ratio is 44.41, indicating healthy liquidity.
Currency: CNY
Cumulative Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Shanghai Serum Bio-Technology, the quick ratio is 42.72, indicating that the company can meet its short-term debt obligations.
Currency: CNY
Cumulative Quarterly
Loading...
ROE
Want to learn more about the financial health of Shanghai Serum Bio-Technology? The latest ROE figure is 5.72%, indicating that the company has stable profitability.
Currency: CNY
Cumulative Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Shanghai Serum Bio-Technology, the total asset return on investment (ROA) is 5.54%.
Currency: CNY
Cumulative Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Shanghai Serum Bio-Technology's latest financial report to see how their gross margin is doing - currently at 78.83%.
Currency: CNY
Cumulative Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Shanghai Serum Bio-Technology, the net profit margin is 36.32%, which is a good sign for its profitability.
Currency: CNY
Cumulative Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data